| Henrik Ehlers Wulff 3 | Chairman of board |
| Henrik Kaj Dvinge 2 | Boardmember |
| Joachim Juel Hagemeister 1 | Boardmember |
| 100% | Novo Nordisk A/S |
| Name | Novo Nordisk Pharmatech A/S |
|---|---|
| CVR | 13246149 |
| Address | Københavnsvej 216, 4600 Køge |
| Industry | Fremstilling af farmaceutiske præparater [212000] |
| Established | 01-07-1989 (30 yr) |
| Company Type | Limited Corporation |
| Number of employees | 170 (Fin.Stmt) |
| Advertising protection | No |
| Auditor | Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab |
| Financial statement period | 01-01 to 31-12 |
| Company capital | 10,000,000 DKK 5,000,000 DKK (31-05-1990 - 25-01-1994) 300,000 DKK (20-07-1989 - 30-05-1990) |
| Articles of assoc. last | 28-08-2015 |
| 2018 | 2017 | 2016 | |
|---|---|---|---|
| Currency/unit | 000' DKK | 000' DKK | 000' DKK |
| Revenue | 690,700 +11% | 622,436 -7% | 669,077 +32% |
| Gross Profit | 283,278 +8% | 263,449 +11% | 237,950 +4% |
| Profit for the Year | 105,268 +2% | 103,665 +19% | 87,367 -5% |
| Equity | 614,221 +16% | 528,953 +13% | 468,288 +17% |
| Total Assets | 760,808 +12% | 676,372 +3% | 653,833 +6% |